
### [NCIT:C91255](http://purl.obolibrary.org/obo/NCIT_C91255)
**Label:** Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage

**Subclasses:** [NCIT:C6009](http://purl.obolibrary.org/obo/NCIT_C6009) (Stage IV Paranasal Sinus Cancer AJCC v7), [NCIT:C6006](http://purl.obolibrary.org/obo/NCIT_C6006) (Stage I Paranasal Sinus Cancer), [NCIT:C6008](http://purl.obolibrary.org/obo/NCIT_C6008) (Stage III Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C6007](http://purl.obolibrary.org/obo/NCIT_C6007) (Stage II Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C4589](http://purl.obolibrary.org/obo/NCIT_C4589) (Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8), [NCIT:C6013](http://purl.obolibrary.org/obo/NCIT_C6013) (Stage I Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C6012](http://purl.obolibrary.org/obo/NCIT_C6012) (Stage II Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C6011](http://purl.obolibrary.org/obo/NCIT_C6011) (Stage III Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C115073](http://purl.obolibrary.org/obo/NCIT_C115073) (Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7), [NCIT:C6010](http://purl.obolibrary.org/obo/NCIT_C6010) (Stage IV Nasal Cavity Carcinoma AJCC v7), [NCIT:C115072](http://purl.obolibrary.org/obo/NCIT_C115072) (Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C115071](http://purl.obolibrary.org/obo/NCIT_C115071) (Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C87498](http://purl.obolibrary.org/obo/NCIT_C87498) (Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8), [NCIT:C94768](http://purl.obolibrary.org/obo/NCIT_C94768) (Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8), [NCIT:C67556](http://purl.obolibrary.org/obo/NCIT_C67556) (Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C115070](http://purl.obolibrary.org/obo/NCIT_C115070) (Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C67554](http://purl.obolibrary.org/obo/NCIT_C67554) (Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C67555](http://purl.obolibrary.org/obo/NCIT_C67555) (Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C89117](http://purl.obolibrary.org/obo/NCIT_C89117) (Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 54.17%
- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40141](http://purl.obolibrary.org/obo/NCIT_C40141) (Wolffian Adnexal Tumor))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40139](http://purl.obolibrary.org/obo/NCIT_C40139) (Uterine Ligament Clear Cell Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40137](http://purl.obolibrary.org/obo/NCIT_C40137) (Uterine Ligament Mucinous Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40129](http://purl.obolibrary.org/obo/NCIT_C40129) (Fallopian Tube Adenomatoid Tumor))) 39.52%


